HUMAN IMMUNODEFICIENCY VIRUS

This early-stage study tested whether two lab-made antibodies (3BNC117 and 10-1074) could safely control HIV when people temporarily stopped their regular antiviral pills. Researchers gave 26 participants with well-controlled HIV seven antibody infusions and monitored if the viru…

This study tested whether group sessions for friends who all have HIV could help them stay in medical care and take their medication consistently. Researchers in Russia worked with 341 people living with HIV, organizing them into friend networks. They compared group support sessi…

This study aimed to help people with HIV whose standard medication combinations were no longer controlling the virus. Researchers closely monitored 26 participants, checking if missed doses or drug resistance was the problem, and then designed new, personalized treatment plans. T…

This study tested whether adding a growth hormone injection to standard HIV medication could shrink the hidden, dormant virus that persists in the body. It involved 22 adults with well-controlled HIV who received daily hormone injections for 48 weeks. The goal was to see if this …

This study tested a special therapy program designed to help people living with HIV quit smoking. The program focused on reducing anxiety and depression, which are common challenges that make quitting harder. Researchers compared this 9-session therapy to standard quit-smoking ad…

This study tested a new support program for pregnant women with HIV in Kenya. The goal was to see if using a risk calculator to identify women who might struggle with their treatment, and then offering them tailored counseling and support, could help them stay in medical care and…

This study tested whether a mobile phone app combined with remote peer support could help people with HIV stay on their medication and keep the virus under control. It focused on Hispanic and Black individuals, including some who use drugs. The goal was to see if this digital app…

This study tested whether adding a special anti-cancer cream after standard surgery could better treat cervical precancer in women living with HIV. Researchers wanted to see if this two-step approach was practical and acceptable to 180 women in South Africa. The goal was to lower…

This early-stage study tested the safety and immune response of a new DNA vaccine, called ICVAX, in people living with HIV who are stable on their regular medication. It involved 45 participants who received different doses of the vaccine or a placebo. The main goal was to see if…

This study tested a new counseling program called THRIVE for people with HIV who were hospitalized and had not been regularly seeing their HIV doctor. The program aimed to help 75 participants overcome feelings of avoidance and stigma so they would continue their outpatient HIV c…

This study tested a program in Kenya designed to encourage more couples to get tested for HIV together during pregnancy. The program involved male-female pairs of community health workers visiting couples at home to offer support and home-based testing. The goal was to increase t…

This study tested whether a mobile chat counseling program could help reduce HIV risk and improve mental health for gay and bisexual men in Romania. 300 HIV-negative men at risk were randomly assigned to receive either eight weekly live chat sessions with a trained counselor or e…

This study tested a new program designed to help gay and bisexual men in Romania start and consistently take daily medication to prevent HIV, known as PrEP. The program combined in-person counseling with a mobile app for support and reminders. Researchers wanted to see if this ap…

This study tested a two-part program to help more women access HIV prevention methods like PrEP. Researchers gave clinic staff special training and offered patients a private tablet tool to learn about their HIV risks and prevention options. The goal was to see if this approach h…

This study examines how well the HPV vaccine protects against infections that can lead to cervical cancer over many years. Researchers followed 3,127 Rwandan women aged 18-28, including those living with and without HIV, to compare infection rates between vaccinated and unvaccina…

This study aimed to understand if the types of bacteria living in the anus are linked to HPV infection and pre-cancerous changes in Hispanic adults living with HIV. Researchers collected swab samples and medical data from 217 participants in California, Mexico, and Puerto Rico to…

This study aimed to understand how well HIV treatment works for transgender and non-binary people living with HIV across Europe. Researchers followed 200 participants for 18 months, collecting health data and surveying their experiences with stigma, medication, and healthcare. Th…